Trade Summary

3 days ago, Ciaramella Giuseppe, serving as Pres at Beam Therapeutics Inc. (BEAM), sold 35,000 shares at $32.00 per share, for a total transaction value of $1,120,042.00. Following this transaction, Ciaramella Giuseppe now holds 190,216 shares of BEAM.

This sale represents a 16.00% decrease in Ciaramella Giuseppe's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 2 days after the trade was made.

Beam Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.